Published in Clin Infect Dis on April 01, 1994
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother (1997) 5.76
Fungal infections: a growing threat. Public Health Rep (1996) 2.59
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob Agents Chemother (1995) 2.37
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study. Haematologica (2010) 1.91
Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol (1999) 1.77
Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol (2003) 1.49
DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol (2007) 1.25
Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis (1997) 1.25
Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16
Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens. Eur J Clin Microbiol Infect Dis (2007) 1.13
PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies. J Clin Microbiol (1999) 1.12
Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention. J Pharm Bioallied Sci (2010) 1.10
A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK. Eur J Haematol (2007) 0.99
Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of D-arabinitol/L-arabinitol ratios in urine. J Clin Microbiol (1997) 0.95
A virtual infection model quantifies innate effector mechanisms and Candida albicans immune escape in human blood. PLoS Comput Biol (2014) 0.91
Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same. Clin Infect Dis (1994) 0.86
Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood (2015) 0.84
Invasive and Allergic Fungal Sinusitis. Curr Infect Dis Rep (2002) 0.83
Candida bracarensis bloodstream infection in an immunocompromised patient. J Clin Microbiol (2010) 0.82
Bottom-up modeling approach for the quantitative estimation of parameters in pathogen-host interactions. Front Microbiol (2015) 0.81
Epidemiology and Prevention of Invasive Aspergillosis. Curr Infect Dis Rep (2001) 0.80
Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans. Clin Diagn Lab Immunol (1997) 0.79
Disseminated mucormycosis in a patient with acute myeloblastic leukemia misdiagnosed as infection by Enterococcus faecium. J Clin Microbiol (2004) 0.78
Practical modalities for prevention of fungal infections in cancer patients. Eur J Clin Microbiol Infect Dis (1997) 0.76
Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis. Antimicrob Agents Chemother (2004) 0.75
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection. Support Care Cancer (2006) 0.75
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci U S A (1997) 3.20
[Treatment and prevention of generalized mycoses]. Ned Tijdschr Geneeskd (1995) 2.03
Skin biopsies in bone marrow transplantation. Lancet (1994) 1.95
Aspergillus peritonitis in peritoneal dialysis: case report and a review of the literature. Nephrol Dial Transplant (1995) 1.67
Stevens-Johnson syndrome after fluconazole. Lancet (1991) 1.63
Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood (1995) 1.62
Interferon-alpha as maintenance therapy in patients with multiple myeloma. Ann Oncol (2005) 1.55
[Mycetoma of the foot; a disease from the tropics]. Ned Tijdschr Geneeskd (1993) 1.50
Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci U S A (1999) 1.49
Tenosynovitis due to Mycobacterium avium-intracellulare: case report and a review of the literature. Clin Exp Rheumatol (1992) 1.48
[Predictive value of chills in patients presenting with fever to urgent care department]. Ned Tijdschr Geneeskd (2002) 1.44
Cord blood banking. Vox Sang (2008) 1.41
[Liver damage during administration of itraconazole (Trisporal)]. Ned Tijdschr Geneeskd (1993) 1.41
[Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia]. Ned Tijdschr Geneeskd (2006) 1.40
Differentiation of follicular lymphoma cells after autologous bone marrow transplantation and haematopoietic growth factor treatment. Lancet (1995) 1.40
Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia. Ann Hematol (1991) 1.39
Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorsus (formerly DF-2) septicemia--a complication of dog bite. Medicine (Baltimore) (1991) 1.38
[Immune response following preventive intracutaneous rabies vaccination]. Ned Tijdschr Geneeskd (1991) 1.38
Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun (1990) 1.32
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis (1993) 1.29
Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes. Blood (1986) 1.28
Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood (1999) 1.23
Clonal hematopoiesis in patients with acquired aplastic anemia. Blood (1991) 1.22
Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant (2010) 1.20
Analysis of gene expression in subpopulations of murine hematopoietic stem and progenitor cells. Exp Hematol (2000) 1.19
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet (1990) 1.19
The molecular basis of leukocytosis. Immunol Today (1998) 1.16
Studies on clonality by PCR analysis of the PGK-1 gene. Nucleic Acids Res (1991) 1.16
Simultaneous production of interleukin 6, interferon-beta and colony-stimulating activity by fibroblasts after viral and bacterial infection. Eur J Immunol (1989) 1.16
Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J Clin Oncol (1997) 1.13
Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood (1996) 1.13
The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc Natl Acad Sci U S A (1998) 1.11
Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect Tissue Res (2007) 1.11
Inhibition of human macrophage colony formation by interleukin 4. J Exp Med (1989) 1.10
Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells. J Clin Invest (1988) 1.05
Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. Blood (1998) 1.05
Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J Exp Med (1988) 1.03
Body weight recovery, eating difficulties and compliance with dietary advice in the first year after stem cell transplantation: a prospective study. Bone Marrow Transplant (2002) 1.02
Detection of trisomy 8 in hematological disorders by in situ hybridization. Cytogenet Cell Genet (1991) 1.02
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis (2001) 1.02
IL-2 dependence of IL-9 expression in human T lymphocytes. J Immunol (1992) 1.01
Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath "in the bag" as T-cell depletion: the Leiden experience. Bone Marrow Transplant (2006) 1.01
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis (2007) 1.01
Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells. J Exp Med (1992) 1.00
Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol (1986) 1.00
Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Exp Med (1991) 0.99
Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg (Torino) (2008) 0.98
Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears. Blood (1992) 0.96
Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymphokine Cytokine Res (1991) 0.96
Isolation of vancomycin-resistant enterococci in haematologic patients. Eur J Clin Microbiol Infect Dis (1991) 0.95
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. J Infect (1991) 0.95
Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation (1999) 0.95
Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. Antimicrob Agents Chemother (1992) 0.95
Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient. Br J Haematol (1989) 0.95
Prognostic factors in IgD myeloma: a study of 21 cases. Scand J Haematol (1984) 0.95
Assessment of telomere length in hematopoietic interphase cells using in situ hybridization and digital fluorescence microscopy. Cytometry (1998) 0.94
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum (2001) 0.94
Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci U S A (1995) 0.94
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol (1999) 0.93
Stem cell transplantation in Europe: trends and prospects. Eur J Cancer (2007) 0.92
Human erythroid progenitor cells express Rhesus antigens. Blood (1985) 0.92
T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci U S A (1998) 0.92
Human hematopoietic progenitor cells in long-term cultures express HLA-DR antigens and lack HLA-DQ antigens. J Exp Med (1985) 0.91
Murine hematopoietic progenitor cells with colony-forming or radioprotective capacity lack expression of the beta 2-integrin LFA-1. Blood (1999) 0.91
Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant (1999) 0.89
Mechanisms underlying hematopoietic stem cell mobilization induced by the CXC chemokine interleukin-8. Curr Opin Hematol (1999) 0.87
T cells selectively infiltrate bone marrow areas with residual haemopoiesis of patients with acquired aplastic anaemia. Br J Haematol (1997) 0.87
A novel murine cathelin-like protein expressed in bone marrow. FEBS Lett (1996) 0.86
Neutropenia and infections in Felty's syndrome. Br J Rheumatol (1988) 0.86
Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications. Leukemia (2011) 0.85
Interleukin-4. A regulatory protein. Blut (1990) 0.85
Chlamydia trachomatis pneumonia in an HIV-seropositive patient. N Engl J Med (1989) 0.85
Meningitis caused by Capnocytophaga canimorsus: when to expect the unexpected. Clin Neurol Neurosurg (2007) 0.85
Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome. Arthritis Rheum (1990) 0.84
Interleukin 1 as a cytokine inducer. Immunobiology (1986) 0.84
t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Cancer Genet Cytogenet (1993) 0.84
Selective decontamination in bone marrow transplant recipients. Epidemiol Infect (1992) 0.83
Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood. Br J Haematol (1998) 0.83
In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation. Bone Marrow Transplant (1992) 0.83
Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products. Cytotherapy (2008) 0.83
Biology and treatment of myelodysplastic syndromes--developments in the past decade. Ann Hematol (1993) 0.83
Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood (1992) 0.83
Different repopulation kinetics of CD3+, 4+ and or 8+ T cells and CD3+, 4-, 8- T cells after allogeneic bone marrow transplantation. Transplant Proc (1989) 0.82
Cell-mediated lysis of human hematopoietic progenitor cells. Leukemia (1987) 0.82
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells. Bone Marrow Transplant (2000) 0.82
Factors influencing the incidence of infections in Felty's syndrome. Arch Intern Med (1987) 0.81
Treatment of postoperative Aspergillus fumigatus spondylodiscitis with itraconazole. Scand J Infect Dis (1991) 0.81
Interleukin-6 is not involved in the interleukin-1-induced production of colony-stimulating factors by human bone marrow stromal cells and fibroblasts. Blood (1989) 0.80
Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome. Bone Marrow Transplant (2001) 0.80
Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience. J Rheumatol Suppl (2001) 0.80
Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor. Exp Hematol (1996) 0.80
Interleukin 4 down-regulates the expression of CD14 and the production of interleukin 6 in acute myeloid leukemia cells. Lymphokine Cytokine Res (1991) 0.79
High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma. Ann Hematol (1995) 0.79
Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase. J Exp Med (1996) 0.79
Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: a potentiating role for amsacrine. Ann Hematol (1991) 0.79